{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:17:11Z","timestamp":1790817431630,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Delirium is a serious complication in patients with COVID-19-related acute respiratory distress syndrome (ARDS) admitted to the intensive care unit (ICU). Although numerous clinical risk factors have been identified, the immunologic pathways underlying delirium remain unclear. In this retrospective cohort study, we investigated high-dimensional immune signatures in ICU patients to delineate peripheral immune markers associated with delirium. We also explored machine learning (ML) approaches to enhance biomarker discovery and strengthen predictive modelling through synthetic data generation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied a cohort of 62 COVID-19 ARDS patients admitted to the ICU at Lausanne University Hospital, Switzerland. The primary analysis compared patients within this cohort who developed delirium (n\u2009=\u200939) to those who remained delirium-free (n\u2009=\u200923). As a baseline for disease severity, we also compared the ICU cohort to 55 non-ICU COVID-19 patients and 450 healthy individuals. We performed high-dimensional immunophenotyping of cytokines, chemokines, and growth factors using multiplex beads assay, along with immune cell profiling via mass cytometry (CyTOF). Ridge regression has been employed to build classification models. We also generated synthetic samples using beta-variational autoencoders to improve sample size and subsequently model stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Delirious patients exhibited a distinctive immune signature, including elevated CXCL1, CCL11, CXCL13, HGF, and VEGF-A, coupled with reduced IL-1\u03b1, IL-21, and IL-22. Alterations in immune cell populations featured increased exhausted B cells and decreases in CXCR3\u2009+\u2009CD4\u2009+\u2009T cells, IgM\u2009+\u2009unswitched memory B cells, and HLA-DR\u2009+\u2009activated T cells. Leveraging these high-dimensional data, we trained ridge regression models to predict delirium. Incorporating synthetic data helped stabilize the models with a best-performing model achieving an area under the curve (AUC) of 0.95, with high sensitivity (93%) and specificity (86%), based on 12 identified markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate a distinct immune profile linked to ICU delirium and illustrate how ML can enhance biomarker discovery. Further prospective validation may refine these markers and guide precision-targeted interventions for mitigating delirium in critically ill populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-025-00825-w","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:49:14Z","timestamp":1762915754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unravelling the complex inflammatory landscape of COVID-19 infection: a pathway to biomarkers identification in infection-associated delirium in the ICU"],"prefix":"10.1186","volume":"13","author":[{"given":"Tristan","family":"Born","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Perreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Paul","family":"Axisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawfel","family":"Ben-Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Du Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-344X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Bernard-Valnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"825_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00223-4","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C et al (2020) Delirium. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-020-00223-4","journal-title":"Nat Rev Dis Primers"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","volume":"369","author":"PP Pandharipande","year":"2013","unstructured":"Pandharipande PP, Girard TD, Jackson JC et al (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369:1306\u20131316. https:\/\/doi.org\/10.1056\/NEJMoa1301372","journal-title":"N Engl J Med"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.n1007","volume":"373","author":"ME Wilcox","year":"2021","unstructured":"Wilcox ME, Girard TD, Hough CL (2021) Delirium and long term cognition in critically ill patients. BMJ 373:1\u201318. https:\/\/doi.org\/10.1136\/bmj.n1007","journal-title":"BMJ"},{"key":"825_CR4","doi-asserted-by":"publisher","first-page":"104043","DOI":"10.1016\/j.ebiom.2022.104043","volume":"80","author":"VJ Page","year":"2022","unstructured":"Page VJ, Watne LO, Heslegrave A et al (2022) Plasma neurofilament light chain protein as a predictor of days in delirium and deep sedation, mortality and length of stay in critically ill patients. EBioMedicine 80:104043. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104043","journal-title":"EBioMedicine"},{"key":"825_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201162","author":"R Bernard-Valnet","year":"2022","unstructured":"Bernard-Valnet R, Favre E, Bernini A et al (2022) Delirium in adults with COVID-19\u2013related ARDS: comparison with other etiologies. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000201162","journal-title":"Neurology"},{"key":"825_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S2213-2600(20)30552-X","volume":"9","author":"BT Pun","year":"2021","unstructured":"Pun BT, Badenes R, Heras La Calle G et al (2021) Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med 9:239\u2013250. https:\/\/doi.org\/10.1016\/S2213-2600(20)30552-X","journal-title":"Lancet Respir Med"},{"key":"825_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19:919\u2013929. https:\/\/doi.org\/10.1016\/S1474-4422(20)30308-2","journal-title":"Lancet Neurol"},{"key":"825_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cell.2022.01.012","volume":"185","author":"DJ Ahern","year":"2022","unstructured":"Ahern DJ, Ai Z, Ainsworth M et al (2022) A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185:916-938.e58. https:\/\/doi.org\/10.1016\/j.cell.2022.01.012","journal-title":"Cell"},{"key":"825_CR9","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/nxi.0000000000001029","volume":"8","author":"R Bernard-Valnet","year":"2021","unstructured":"Bernard-Valnet R, Perriot S, Canales M et al (2021) Encephalopathies associated with severe COVID-19 present neurovascular unit alterations without evidence for strong neuroinflammation. Neurol Neuroimmunol Neuroinflamm 8:e1029. https:\/\/doi.org\/10.1212\/nxi.0000000000001029","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"825_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30404-5","author":"DE Leisman","year":"2020","unstructured":"Leisman DE, Ronner L, Pinotti R et al (2020) Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. https:\/\/doi.org\/10.1016\/s2213-2600(20)30404-5","journal-title":"Lancet Respir Med"},{"key":"825_CR11","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","volume":"13","author":"MM Etter","year":"2022","unstructured":"Etter MM, Martins TA, Kulsvehagen L et al (2022) Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun 13:6777. https:\/\/doi.org\/10.1038\/s41467-022-34068-0","journal-title":"Nat Commun"},{"key":"825_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13613-019-0548-1","volume":"9","author":"K Toft","year":"2019","unstructured":"Toft K, Tontsch J, Abdelhamid S et al (2019) Serum biomarkers of delirium in the elderly: a narrative review. Ann Intensive Care 9:76. https:\/\/doi.org\/10.1186\/s13613-019-0548-1","journal-title":"Ann Intensive Care"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","volume":"286","author":"EW Ely","year":"2001","unstructured":"Ely EW, Inouye SK, Bernard GR et al (2001) Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA 286:2703. https:\/\/doi.org\/10.1001\/jama.286.21.2703","journal-title":"JAMA"},{"key":"825_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s001340100909","volume":"27","author":"N Bergeron","year":"2001","unstructured":"Bergeron N, Dubois M-J, Dumont M et al (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27:859\u2013864. https:\/\/doi.org\/10.1007\/s001340100909","journal-title":"Intensive Care Med"},{"key":"825_CR15","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2211868","volume":"387","author":"NC Andersen-Ranberg","year":"2022","unstructured":"Andersen-Ranberg NC, Poulsen LM, Perner A et al (2022) Haloperidol for the treatment of delirium in ICU patients. N Engl J Med 387:2425\u20132435. https:\/\/doi.org\/10.1056\/NEJMoa2211868","journal-title":"N Engl J Med"},{"key":"825_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccc.2016.12.005","volume":"33","author":"A Marra","year":"2017","unstructured":"Marra A, Ely EW, Pandharipande PP, Patel MB (2017) The ABCDEF bundle in critical care. Crit Care Clin 33:225\u2013243. https:\/\/doi.org\/10.1016\/j.ccc.2016.12.005","journal-title":"Crit Care Clin"},{"key":"825_CR17","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1038\/s41467-021-25191-5","volume":"12","author":"M Perreau","year":"2021","unstructured":"Perreau M, Suffiotti M, Marques-Vidal P et al (2021) The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat Commun 12:4888. https:\/\/doi.org\/10.1038\/s41467-021-25191-5","journal-title":"Nat Commun"},{"key":"825_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"The RECOVERY Collaborative Group","year":"2021","unstructured":"The RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"825_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16:155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"key":"825_CR20","doi-asserted-by":"publisher","first-page":"e0729","DOI":"10.1097\/CCE.0000000000000729","volume":"4","author":"RJ Smith","year":"2022","unstructured":"Smith RJ, Rabinstein AA, Cartin-Ceba R et al (2022) Chemokines in ICU delirium: an exploratory study. Crit Care Explor 4:e0729. https:\/\/doi.org\/10.1097\/CCE.0000000000000729","journal-title":"Crit Care Explor"},{"key":"825_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4266\/acc.2021.01508","volume":"37","author":"RJ Smith","year":"2022","unstructured":"Smith RJ, Lachner C, Singh VP et al (2022) Cytokine profiles in intensive care unit delirium. Acute Crit Care 37:415\u2013428. https:\/\/doi.org\/10.4266\/acc.2021.01508","journal-title":"Acute Crit Care"},{"key":"825_CR22","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/cbin.11832","volume":"46","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Jiang J, Liu Y et al (2022) Activated microglia promote invasion and barrier dysfunction of brain endothelial cells via regulating the CXCL13\/CXCR5 axis. Cell Biol Int 46:1510\u20131518. https:\/\/doi.org\/10.1002\/cbin.11832","journal-title":"Cell Biol Int"},{"key":"825_CR23","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1172\/JCI60842","volume":"122","author":"AT Argaw","year":"2012","unstructured":"Argaw AT, Asp L, Zhang J et al (2012) Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122:2454\u20132468. https:\/\/doi.org\/10.1172\/JCI60842","journal-title":"J Clin Invest"},{"key":"825_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12974-021-02300-1","volume":"18","author":"Y Shen","year":"2021","unstructured":"Shen Y, Zhang Y, Du J et al (2021) Cxcr5 down-regulation alleviates cognitive dysfunction in a mouse model of sepsis-associated encephalopathy: potential role of microglial autophagy and the p38MAPK\/NF-\u03baB\/STAT3 signaling pathway. J Neuroinflamm 18:246. https:\/\/doi.org\/10.1186\/s12974-021-02300-1","journal-title":"J Neuroinflamm"},{"key":"825_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12974-020-02013-x","volume":"17","author":"Y Shen","year":"2020","unstructured":"Shen Y, Zhang Y, Chen L et al (2020) Chemokine CXCL13 acts via CXCR5-ERK signaling in hippocampus to induce perioperative neurocognitive disorders in surgically treated mice. J Neuroinflamm 17:335. https:\/\/doi.org\/10.1186\/s12974-020-02013-x","journal-title":"J Neuroinflamm"},{"key":"825_CR26","doi-asserted-by":"publisher","first-page":"108150","DOI":"10.1016\/j.celrep.2020.108150","volume":"32","author":"BD Michael","year":"2020","unstructured":"Michael BD, Bricio-Moreno L, Sorensen EW et al (2020) Astrocyte- and neuron-derived CXCL1 drives neutrophil transmigration and blood-brain barrier permeability in viral encephalitis. Cell Rep 32:108150. https:\/\/doi.org\/10.1016\/j.celrep.2020.108150","journal-title":"Cell Rep"},{"key":"825_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12974-018-1138-0","volume":"15","author":"S Grygorczuk","year":"2018","unstructured":"Grygorczuk S, \u015awierzbi\u0144ska R, Kondrusik M et al (2018) The intrathecal expression and pathogenetic role of Th17 cytokines and CXCR2-binding chemokines in tick-borne encephalitis. J Neuroinflamm 15:115. https:\/\/doi.org\/10.1186\/s12974-018-1138-0","journal-title":"J Neuroinflamm"},{"key":"825_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01238-8","author":"G Bieri","year":"2023","unstructured":"Bieri G, Schroer AB, Villeda SA (2023) Blood-to-brain communication in aging and rejuvenation. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-022-01238-8","journal-title":"Nat Neurosci"},{"key":"825_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI et al (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477:90\u201394. https:\/\/doi.org\/10.1038\/nature10357","journal-title":"Nature"},{"key":"825_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-015-0335-3","volume":"12","author":"G Perriard","year":"2015","unstructured":"Perriard G, Mathias A, Enz L et al (2015) Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflamm 12:119. https:\/\/doi.org\/10.1186\/s12974-015-0335-3","journal-title":"J Neuroinflamm"},{"key":"825_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/SHK.0000000000000619","volume":"46","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Inoue S, Kametani Y et al (2016) Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis. Shock 46:270\u2013278. https:\/\/doi.org\/10.1097\/SHK.0000000000000619","journal-title":"Shock"},{"key":"825_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/CCM.0000000000004309","volume":"48","author":"X Dong","year":"2020","unstructured":"Dong X, Liu Q, Zheng Q et al (2020) Alterations of B cells in immunosuppressive phase of septic shock patients*. Crit Care Med 48:815\u2013821. https:\/\/doi.org\/10.1097\/CCM.0000000000004309","journal-title":"Crit Care Med"},{"key":"825_CR33","doi-asserted-by":"publisher","first-page":"R220","DOI":"10.1186\/cc10457","volume":"15","author":"J-F Wu","year":"2011","unstructured":"Wu J-F, Ma J, Chen J et al (2011) Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care 15:R220. https:\/\/doi.org\/10.1186\/cc10457","journal-title":"Crit Care"},{"key":"825_CR34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00134-015-3777-2","volume":"41","author":"A Wassenaar","year":"2015","unstructured":"Wassenaar A, Van Den Boogaard M, Van Achterberg T et al (2015) Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med 41:1048\u20131056. https:\/\/doi.org\/10.1007\/s00134-015-3777-2","journal-title":"Intensive Care Med"},{"key":"825_CR35","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1136\/bmj.e420","volume":"344","author":"MVD Boogaard","year":"2012","unstructured":"Boogaard MVD, Pickkers P, Slooter AJC et al (2012) Development and validation of PRE-DELIRIC (prediction of delirium in ICU patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 344:e420\u2013e420. https:\/\/doi.org\/10.1136\/bmj.e420","journal-title":"BMJ"},{"key":"825_CR36","doi-asserted-by":"publisher","first-page":"e0296","DOI":"10.1097\/CCE.0000000000000296","volume":"2","author":"MM Ruppert","year":"2020","unstructured":"Ruppert MM, Lipori J, Patel S et al (2020) ICU delirium-prediction models: a systematic review. Crit Care Explor 2:e0296. https:\/\/doi.org\/10.1097\/CCE.0000000000000296","journal-title":"Crit Care Explor"},{"key":"825_CR37","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C et al (2018) Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 46:e825\u2013e873. https:\/\/doi.org\/10.1097\/CCM.0000000000003299","journal-title":"Crit Care Med"},{"key":"825_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S et al (2022) Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 18:158\u2013172. https:\/\/doi.org\/10.1038\/s41582-021-00616-3","journal-title":"Nat Rev Neurol"},{"key":"825_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/ane.13447","volume":"144","author":"E Eskioglou","year":"2021","unstructured":"Eskioglou E, Iaquaniello C, Alvarez V et al (2021) Electroencephalography of mechanically ventilated patients at high risk of delirium. Acta Neuro Scand 144:296\u2013302. https:\/\/doi.org\/10.1111\/ane.13447","journal-title":"Acta Neuro Scand"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00825-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:49:15Z","timestamp":1762915755000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00825-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00825-w","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Ethics Committee (CER-VD) under the CORO-NEURO study (authorization n\n                      o\n                      . 2020-01123). Informed consent was obtained from all living participants; however, it was waived for those who had passed away.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TB holds shares in Pfizer Inc. (PFE) and Novartis AG (NOVN). MP has nothing to disclose. CF has nothing to disclose. NBH has nothing to disclose. AOR has nothing to disclose. RDP has nothing to disclose. JDC has nothing to disclose. RBV has received travel and speaking\/advisory board honoraria from Merck, Roche,\u00a0Juvis\u00e9, Sanofi and Novartis, and research support from the Novartis Foundation, all unrelated to the current work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}